“Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients ”. Journal of Cancer Research Updates, vol. 1, no. 1, Jan. 2012, pp.  44-48, https://doi.org/10.6000/1929-2279.2012.01.01.08.